Recent FBLG News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2026 09:03:48 PM
- FibroBiologics Completes Site Onboarding for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers • GlobeNewswire Inc. • 03/05/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 01:00:15 PM
- Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them • PR Newswire (US) • 03/03/2026 03:02:00 PM
- Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them • PR Newswire (Canada) • 03/03/2026 03:02:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2026 02:15:05 PM
- FibroBiologics, Inc. Announces Issuance of U.S. Patent Covering Fibroblast Cell Therapy for the Treatment of Osteoporosis • GlobeNewswire Inc. • 03/02/2026 01:30:00 PM
- FibroBiologics to Present at the BIO Investment & Growth Summit • GlobeNewswire Inc. • 02/26/2026 01:30:00 PM
- FibroBiologics Reports Full Year 2025 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 02/24/2026 09:30:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/24/2026 09:06:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2026 09:18:54 PM
- FibroBiologics Granted Extension by Nasdaq to Regain Compliance • GlobeNewswire Inc. • 02/23/2026 01:30:00 PM
- FibroBiologics’ Chairman & CEO Pete O’Heeron Selected to Present at A4LI’s H-SPAN Summit at Georgetown University • GlobeNewswire Inc. • 02/10/2026 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2026 09:10:23 PM
- FibroBiologics Announces Issuance of Canadian Patent Covering Novel Fibroblast-Based Treatment for Cachexia • GlobeNewswire Inc. • 02/05/2026 01:30:00 PM
- FibroBiologics to Present at the DealFlow Discovery Conference • GlobeNewswire Inc. • 01/20/2026 01:30:00 PM
- FibroBiologics CEO Issues Letter to Shareholders • GlobeNewswire Inc. • 01/07/2026 01:30:00 PM
- FibroBiologics to Present at 9th Annual BFC Global Healthcare Business Development and Investment Conference • GlobeNewswire Inc. • 01/06/2026 01:30:00 PM
- FibroBiologics Announces Positive Preclinical Results for a Fibroblast Spheroid-derived Chondrocyte (FSdC) Spheroid Therapy for Degenerative Disc Disease • GlobeNewswire Inc. • 01/05/2026 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:15:25 PM
- FibroBiologics Files IND Application with the U.S. FDA to Advance Clinical Development of CYPS317 in Patients with Psoriasis • GlobeNewswire Inc. • 12/31/2025 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/31/2025 05:15:36 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/30/2025 09:45:16 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/29/2025 02:34:46 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/29/2025 02:31:58 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
